mTORC1 sustains vision in retinitis pigmentosa by Petit, Lolita & Punzo, Claudio
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2015-07-10 
mTORC1 sustains vision in retinitis pigmentosa 
Lolita Petit 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Eye Diseases Commons, Molecular and Cellular Neuroscience Commons, and the 
Ophthalmology Commons 
Repository Citation 
Petit L, Punzo C. (2015). mTORC1 sustains vision in retinitis pigmentosa. Open Access Articles. 
https://doi.org/10.18632/oncotarget.4466. Retrieved from https://escholarship.umassmed.edu/oapubs/
2694 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Oncotarget16786www.impactjournals.com/oncotarget
www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No. 19
mTORC1 sustains vision in retinitis pigmentosa
Lolita Petit and Claudio Punzo
Photoreceptors are highly specialized neurons that 
have evolved to optimally capture photons. Understanding 
their demise, in order to develop therapeutic strategies, has 
the potential to improve the quality of life of millions of 
patients.
Retinitis pigmentosa (RP) is the most frequent form 
of inherited photoreceptor degeneration. In many cases, 
the genetic defects are specific to the night active rod 
photoreceptors; however, cones, which mediate daytime 
and high acuity vision, die as well [1]. The dependence of 
cones on rods has puzzled the field of retinal biology for 
decades. Many hypotheses have been proposed that are 
supported by experimental evidence; however, the delay 
in cone death has been minimal and short-lived.
We recently proposed a new model where cone loss 
is caused by a nutrient shortage (particularly glucose) 
induced by the collapse of the retinal architecture as 
rods die [2]. In the retina, rods and cones are densely 
packed into the same layer. Because rods account for 
over 95% of photoreceptors, their loss profoundly 
affects the retinal structure making cones vulnerable. 
Our hypothesis for cone loss was based on the findings 
that cones increase the expression of metabolic genes at 
the onset of cone death, and display signs of prolonged 
starvation during degeneration. These changes were 
accompanied by changes in the insulin/mammalian target 
of rapamycin (mTOR) pathway, a pathway that regulates 
cell metabolism by balancing demand with supply. To 
test the role of this pathway during cone degeneration, 
we treated the retinal degeneration-1 mouse model of RP 
with daily systemic injections of insulin. Similar to the 
experimental evidence of previous hypotheses the effects 
of insulin were not long lasting, albeit substantial. This 
short-lived effect may have been caused by the feedback 
loop within the pathway, which causes cells to become 
insulin resistant over time [3].
To circumvent the feedback-loop, test if insulin 
acted directly on cones, and test the long-term therapeutic 
potential of the pathway on cone survival we took a 
genetic approach using various conditional alleles of 
genes downstream of the insulin receptor, that when 
deleted either increase or ablate mTOR activity. Deletion 
in cones of the two negative regulators of mTOR, the 
phosphatase and tensin homologue (Pten) and the tuberous 
sclerosis complex 1 (Tsc1), both significantly prolonged 
cone survival while deletion of Raptor, the accessory 
protein of the mTOR complex 1 (mTORC1), accelerated 
cone death during disease [3, 4]. Concomitant loss of 
Pten and Raptor, as well as Tsc1 and Raptor, and Tsc1 
and Rictor, the mTORC2 accessory protein, confirmed 
that the insulin-mediated effect on cone survival was 
indeed driven by mTORC1. Because the effect on cone 
survival upon loss of Tsc1 was the most robust and long 
lasting described thus far, the data supports the idea that 
nutrient shortage may be the overarching problem cones 
face as rods die. This can be explained by the high-energy 
demand of photoreceptors. In a healthy retina in addition 
to re-equilibrating membrane potentials photoreceptors 
need to synthesize membranes and proteins at a rate 
equivalent to one cell division per day, as these are lost 
in the daily shedding of their photosensitive structure 
[5]. Additionally, photoreceptors need to synthesize large 
quantities of NADPH to neutralize free radicals produced 
by incident light and the high metabolic rate, making them 
one of the highest energy consuming cells in the body [6].
To sustain their metabolic needs photoreceptors have 
a high glycolytic rate that is accompanied by secretion of 
lactate in the presence of ample oxygen, a phenomenon 
known as the Warburg effect and typically found in cancer 
cells. Like proliferating cells, photoreceptors thus express 
high levels of hexokinase II and pyruvate kinase-2. In 
dividing cells these genes are regulated by mTORC1, 
which controls a wide range of metabolic pathways 
including glycolysis, fatty acid synthesis and the pentose 
phosphate pathway. It is thus not surprising that loss of 
Tsc1 increased the expression of these genes in cones 
in addition to other metabolic genes [4]. Therefore, loss 
of Tsc1 may have promoted cone survival by improving 
glucose uptake, retention, and utilization. Interestingly, 
all of these genes appeared already upregulated in cones 
during disease, albeit to a lesser extend. Loss of Tsc1 
further increased their expression making cones more 
resistant to the nutrient shortage. Consistent with that, 
loss of mTORC1 activity during disease accelerated 
cone death, as cones fail to balance demand with supply, 
while combined loss of Tsc1 and mTORC1 not only 
failed to promote cone survival but resulted in the same 
acceleration of cone death as seen upon loss of mTORC1 
alone. In contrast, loss of mTORC1 in wild-type cones 
had no effect suggesting that mTORC1 is mainly required 
when the metabolic equilibrium is disturbed [7]. 
To test if loss of Tsc1 can promote cone survival in 
other models of RP, we repeated the experiments in the 
slow progressing rhodopsin knockout mouse. Cone death 
was significantly delayed in this model too, indicating 
that increasing mTORC1 activity has broad therapeutic 
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implications for RP [4]. While many mTORC1 inhibitors 
have been identified due to their ability to reduce 
proliferation in cancers our findings highlight the need to 
identify activators of mTORC1 that could be beneficial for 
other diseases.
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